Utilization of interleukin-1 antagonists for management of recurrent pericarditis

Elsevier

Available online 17 December 2025

The American Journal of the Medical SciencesAuthor links open overlay panel, , , , , Section snippetsDeclaration of competing interest

Dr. Allan Klein is the principal investigator of the RHAPSODY trial. The remaining authors have no conflicts of interest. There was no financial funding provided for this project.

References (7)

There are more references available in the full text version of this article.

View full text

© 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Comments (0)

No login
gif